Final rule 2025-23413
Medical Devices; Neurological Devices; Classification of the Electrical Tongue Nerve Stimulator To Treat Motor Deficits
The Food and Drug Administration (FDA, the Agency, or we) is classifying the electrical tongue nerve stimulator to treat motor deficits into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the classification of the electrical tongue nerve stimulator to treat motor deficits. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Source-supplied record
Document details
- Document number
- 2025-23413
- Published
- Dec 19, 2025
- Effective
- Dec 19, 2025
- Comments close
- Not supplied
- Federal Register citation
- 90 FR 59377
Docket identifiers
- Docket No. FDA-2025-N-6025
CFR references
- Title 21, part 882